Gardnerella vaginalis in Symptomatic Men: Prevalence, Load, and Co-infections
Understanding *Gardnerella vaginalis* and Men’s Health
Table of Contents
Published october 18, 2025
The Rising Awareness of *Gardnerella vaginalis* in Men
For years, *Gardnerella vaginalis* was primarily associated with bacterial vaginosis (BV) in women. however, recent research is revealing a significant presence of this bacterium in men, even those experiencing symptoms of urogenital issues. A study published in Cureus investigated the prevalence, bacterial load, and co-infections of *G. vaginalis* in symptomatic men, shedding light on a previously underrecognized aspect of men’s health.
Prevalence and Bacterial Load in Symptomatic Men
The Cureus study, conducted between January 2023 and December 2023, analyzed data from 188 men presenting with urogenital symptoms. Researchers found that *G. vaginalis* was present in 37.8% of these men. Importantly, the study categorized bacterial load as low, medium, or high, revealing that a considerable portion of those infected carried a medium to high load of the bacteria.This suggests that *G. vaginalis* isn’t simply a coincidental finding, but potentially a contributing factor to their symptoms.
Common Co-infections
The research also highlighted the frequent occurrence of co-infections alongside *G. vaginalis*. The most common co-infection observed was *Mycoplasma genitalium*, found in 17.6% of the men with *G. vaginalis*. Other co-infections included *Ureaplasma urealyticum* (11.7%), *Chlamydia trachomatis* (6.9%), and *Neisseria gonorrhoeae* (3.2%). These findings emphasize the complex interplay of microorganisms in the urogenital tract and the importance of comprehensive testing.
symptoms and Diagnostic Challenges
Men in the study presented with a range of symptoms, including urethritis (inflammation of the urethra), prostatitis (inflammation of the prostate), and epididymitis (inflammation of the epididymis). However, it’s crucial to note that *G. vaginalis* infection in men frequently enough doesn’t present with obvious symptoms, making diagnosis challenging. Current diagnostic methods, such as PCR testing, are becoming increasingly available to accurately identify *G. vaginalis* and its co-infections.
Implications for Treatment and Prevention
The increasing recognition of *G. vaginalis* in men has significant implications for treatment strategies. Given the high rate of co-infections, a broad-spectrum approach to testing and treatment is frequently enough recommended. Further research is needed to determine the optimal antibiotic regimens for *G. vaginalis* in men and to understand the role of sexual transmission and potential preventative measures. Open interaction with healthcare providers is essential for accurate diagnosis and appropriate management of urogenital symptoms.